Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China
· Delayed Price · Currency is CNY 27.90
-0.50 (-1.76%)
At close: Mar 9, 2026
SHA:603983 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 3,466 | 2,968 | 2,225 | 1,730 | 1,726 | 1,744 | Upgrade
|
| Other Revenue | 2.04 | 2.04 | 0.66 | 1.9 | 60.68 | 1.09 | Upgrade
|
| Revenue | 3,468 | 2,970 | 2,226 | 1,732 | 1,787 | 1,745 | Upgrade
|
| Revenue Growth (YoY) | 31.28% | 33.44% | 28.52% | -3.09% | 2.41% | -3.10% | Upgrade
|
| Cost of Revenue | 912.63 | 793.26 | 665.27 | 557.04 | 654.5 | 595.69 | Upgrade
|
| Gross Profit | 2,555 | 2,177 | 1,560 | 1,175 | 1,133 | 1,149 | Upgrade
|
| Selling, General & Admin | 2,117 | 1,743 | 1,307 | 957.43 | 841.66 | 642.71 | Upgrade
|
| Research & Development | 81.9 | 73.54 | 62.29 | 52.93 | 50.49 | 50.15 | Upgrade
|
| Other Operating Expenses | 30.17 | 20.53 | 17.88 | 24.1 | 23.33 | 18.45 | Upgrade
|
| Operating Expenses | 2,228 | 1,837 | 1,385 | 1,037 | 916.19 | 711.36 | Upgrade
|
| Operating Income | 326.97 | 339.19 | 175.31 | 137.59 | 216.34 | 437.94 | Upgrade
|
| Interest Expense | -8.55 | -9.86 | -6.63 | -3.24 | -1.02 | -1.13 | Upgrade
|
| Interest & Investment Income | 45.68 | 44.44 | 65.05 | 43.64 | 60.14 | 87.43 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0.02 | 0.06 | 1.74 | 7.78 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.83 | -0.29 | -0.64 | 0.21 | -0.98 | -0.48 | Upgrade
|
| EBT Excluding Unusual Items | 363.27 | 373.47 | 233.12 | 178.26 | 276.22 | 531.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | 20.85 | -0.98 | 70.98 | 5.29 | 0.61 | -2.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.3 | -0.29 | 0.45 | 0.28 | 0.42 | -0.03 | Upgrade
|
| Asset Writedown | 4.15 | - | - | - | -0.1 | - | Upgrade
|
| Other Unusual Items | 8.45 | 8.45 | 12.53 | 22.75 | 32.47 | 38.43 | Upgrade
|
| Pretax Income | 397.02 | 380.66 | 317.09 | 206.58 | 309.63 | 567.37 | Upgrade
|
| Income Tax Expense | 47.79 | 38.29 | 39.5 | 39.15 | 68.43 | 103.97 | Upgrade
|
| Earnings From Continuing Operations | 349.22 | 342.36 | 277.59 | 167.43 | 241.19 | 463.4 | Upgrade
|
| Minority Interest in Earnings | -2.51 | -0.74 | -18.17 | 6.75 | 6.73 | 1 | Upgrade
|
| Net Income | 346.72 | 341.63 | 259.42 | 174.18 | 247.92 | 464.4 | Upgrade
|
| Net Income to Common | 346.72 | 341.63 | 259.42 | 174.18 | 247.92 | 464.4 | Upgrade
|
| Net Income Growth | 6.88% | 31.69% | 48.93% | -29.74% | -46.62% | -9.81% | Upgrade
|
| Shares Outstanding (Basic) | 403 | 402 | 399 | 405 | 400 | 400 | Upgrade
|
| Shares Outstanding (Diluted) | 403 | 402 | 399 | 405 | 400 | 400 | Upgrade
|
| Shares Change (YoY) | 2.25% | 0.70% | -1.47% | 1.30% | -0.12% | 6.52% | Upgrade
|
| EPS (Basic) | 0.86 | 0.85 | 0.65 | 0.43 | 0.62 | 1.16 | Upgrade
|
| EPS (Diluted) | 0.86 | 0.85 | 0.65 | 0.43 | 0.62 | 1.16 | Upgrade
|
| EPS Growth | 4.53% | 30.77% | 51.16% | -30.64% | -46.55% | -15.33% | Upgrade
|
| Free Cash Flow | 158.75 | -15.85 | 83.98 | -62.47 | -124.62 | -386.57 | Upgrade
|
| Free Cash Flow Per Share | 0.39 | -0.04 | 0.21 | -0.15 | -0.31 | -0.97 | Upgrade
|
| Dividend Per Share | 0.750 | 0.750 | 0.520 | 0.250 | 0.190 | 0.350 | Upgrade
|
| Dividend Growth | -2.60% | 44.23% | 108.00% | 31.58% | -45.71% | -10.26% | Upgrade
|
| Gross Margin | 73.68% | 73.29% | 70.11% | 67.83% | 63.38% | 65.86% | Upgrade
|
| Operating Margin | 9.43% | 11.42% | 7.88% | 7.95% | 12.11% | 25.10% | Upgrade
|
| Profit Margin | 10.00% | 11.50% | 11.66% | 10.06% | 13.87% | 26.61% | Upgrade
|
| Free Cash Flow Margin | 4.58% | -0.53% | 3.77% | -3.61% | -6.97% | -22.15% | Upgrade
|
| EBITDA | 352.03 | 360.74 | 192.17 | 154.13 | 231.83 | 450.59 | Upgrade
|
| EBITDA Margin | 10.15% | 12.15% | 8.63% | 8.90% | 12.97% | 25.82% | Upgrade
|
| D&A For EBITDA | 25.07 | 21.55 | 16.86 | 16.54 | 15.49 | 12.65 | Upgrade
|
| EBIT | 326.97 | 339.19 | 175.31 | 137.59 | 216.34 | 437.94 | Upgrade
|
| EBIT Margin | 9.43% | 11.42% | 7.88% | 7.95% | 12.11% | 25.10% | Upgrade
|
| Effective Tax Rate | 12.04% | 10.06% | 12.46% | 18.95% | 22.10% | 18.32% | Upgrade
|
| Revenue as Reported | 3,468 | 2,970 | 2,226 | 1,732 | 1,787 | 1,745 | Upgrade
|
| Advertising Expenses | - | 1,354 | 956.67 | 656.1 | 544.22 | 423.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.